Published in Drug Week, November 23rd, 2001
"Rash is the most frequent adverse event associated with nevirapine," according to Jose M. Miro, Hospital del Mar, Barcelona, and colleagues in a multicenter study. "The use of prednisone has been controversial in this setting."
The controversy was for good reason - prednisone actually appears to worsen nevirapine-induced rash, according to Miro and coworkers.
They evaluated the safety and efficacy of prednisone in 75 nevirapine-treated patients, 39 of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.